Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × tositumomab I-131 × Clear all

NCT00003784 2013-01-24

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia